Investing

Acceleration of RAD204 Phase 1 dose escalation trial

by admin

Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

Locksley Resources LimitedU.S. Investors Lead Oversubscribed $17m Placement

U.S. Investors Lead Oversubscribed $17m Placement

Editor’s Picks: Silver Price Smashes All-time High, Nearly...

Top 5 Canadian Mining Stocks This Week: Bayhorse...

NioCorp Acquires FEA Materials to Build US Scandium...

Copper Quest Closes $1,927,000 Private Placement